Lotus Tissue Repair's Series A Round

Lotus Tissue Repair raised a round of funding on June 30, 2011. Investors include Third Rock Ventures.

Lotus Tissue Repair is developing its recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating wound healing. T…

Articles about Lotus Tissue Repair's Series A Round: